Latin America Sepsis Diagnostics Market Size, Share, Growth, Trends, and Industry Analsis: By Product (Instruments, Blood Culture Media, Assay Kits and Reagents, Software), By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry), By Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), By Test Type (Laboratory Tests and Point-Of-Care Tests) and Country Forecast 2020-2031

Latin America Sepsis Diagnostics Market size was valued at US$ 194.5 million in 2024 and is expected to reach US$ 322.6 million by 2031, growing at a significant CAGR of 7.5% from 2025-2031. The market provides a detailed overview of the market that can be segmented By Product, Technology, Pathogen, and Testing Type. By Product, the market has been segmented into Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry. The Microbiology segment is likely to be the largest and fastest-growing segment in terms of Product. Based on pathogen type, the market is segmented into Bacterial Sepsis, Fungal Sepsis, and Others. Â Among these, the bacterial sepsis segment is expected to have the fastest-growing market during the forecast period 2024-2030.

By Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Conventional Diagnostics are expected to dominate the market in the future. Based on test type, the market has been segmented into Laboratory Tests and Point-Of-Care Tests. The laboratory tests segment is expected to grow at the highest CAGR over the forecast years. Based on the end-user, the market has been segregated into Hospitals, Pathology & Reference Laboratories. The Hospitals segment is to dominate other segments in the Latin America Sepsis Diagnosticsmarket according to Precision Business Insights.

Key Development:

• In January 2020, Roche and Inotrem SA, a France-based company, formed a strategic agreement for the commercialization of a companion diagnostics test intended for septic shock.